Related Experiment Video
Updated: May 28, 2026

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
Published on: July 11, 2025
Pathology Foundation Models: Evolution, Current Landscape, Challenges and Opportunities from a Technical and Clinical
Hussien Al-Asi1,2, Ibrahim Yilmaz1,2, Jordan Reynolds1
1Department of Laboratory Medicine and Pathology, Mayo Clinic Florida, 4500 San Pablo Rd S, Jacksonville, FL 32224, USA.
Pathology Foundation Models (PFMs) offer scalable, adaptable representations of whole-slide images for diagnostics. Future development requires rigorous benchmarking and multimodal integration for clinical translation.
Area of Science:
- Computational pathology
- Artificial intelligence in histopathology
- Foundation models in medicine
Background:
- Foundation models (PFMs) are revolutionizing computational pathology with scalable, task-agnostic representations of whole-slide images (WSIs).
- PFMs utilize self-supervised Vision Transformer architectures and large WSI datasets for broad generalization and few-shot learning.
- The field has evolved from earlier methods like CLAM and HIPT to large-scale models such as UNI, Virchow, Phikon, CONCH, GigaPath, H-Optimus, TITAN, and the Mayo Clinic Atlas.
Purpose of the Study:
- To review the development of PFMs in computational pathology.
- To critically evaluate the strengths and limitations of current PFMs.
- To outline priorities for the safe and effective clinical translation of PFMs.
Main Methods:
- Review of existing literature on pathology foundation models.
- Analysis of PFM performance across diagnostic and prognostic benchmarks.
- Evaluation of multimodal integration capabilities with genomics and clinical data.
Main Results:
- PFMs demonstrate impressive performance and enable multimodal data integration.
- Significant barriers include inconsistent institutional generalization, lagging interpretability, and slow workflow integration.
- Specific areas like cytopathology and rare tumor subtypes remain challenging for current models.
Conclusions:
- The next phase of PFM development necessitates rigorous benchmarking and pathologist-in-the-loop deployment.
- Multimodal fusion is crucial for advancing PFMs from research tools to clinically robust systems.
- Addressing limitations in generalization, interpretability, and workflow integration is key for clinical translation.
Related Concept Videos
Introduction to Language of Pathophysiology l
Introduction to Language of Pathophysiology ll
Microorganisms in Medicine and Therapeutics
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
